Inhaled statins as bronchodilators to improve lung function in respiratory diseases

摘要

The present disclosure is a method of relaxing airway smooth muscle tissue, alleviating or preventing bronchospasm, and treating lung disease by directly inhaling an HMG-CoA reductase inhibitor (statin) into lung tissue. Regarding. The present disclosure also relates to formulations and compositions useful in carrying out the methods of the present disclosure. [Selection diagram] FIG. 18